HLPCPEPXICVQDA-KWPKBRHLSA-N
C33H38Cl2F4N6O2 — CID 147801421
Data last refreshed: (MolForge compound catalog, from PubChem)
About HLPCPEPXICVQDA-KWPKBRHLSA-N
HLPCPEPXICVQDA-KWPKBRHLSA-N (PubChem CID 147801421) has the molecular formula C33H38Cl2F4N6O2 and a molecular weight of 697.61 g/mol. Its IUPAC name is 6-(3-azabicyclo[3.1.0]hexan-3-yl)-2-[2,6-dichloro-3-[[(2-fluoro-2-methylpropanoyl)amino]methyl]anilino]-1-methyl-N-[[4-(trifluoromethyl)cyclohexyl]methyl]benzimidazole-5-carboxamide.
Molecular Properties
| Compound Name | HLPCPEPXICVQDA-KWPKBRHLSA-N |
|---|---|
| PubChem CID | 147801421 |
| Molecular Formula | C33H38Cl2F4N6O2 |
| Molecular Weight | 697.61 g/mol |
| Exact Mass | 696.24 |
| IUPAC Name | 6-(3-azabicyclo[3.1.0]hexan-3-yl)-2-[2,6-dichloro-3-[[(2-fluoro-2-methylpropanoyl)amino]methyl]anilino]-1-methyl-N-[[4-(trifluoromethyl)cyclohexyl]methyl]benzimidazole-5-carboxamide |
| SMILES | Cn1c(Nc2c(Cl)ccc(CNC(=O)C(C)(C)F)c2Cl)nc2cc(C(=O)NCC3CCC(C(F)(F)F)CC3)c(N3CC4CC4C3)cc21 |
| InChI | InChI=1S/C33H38Cl2F4N6O2/c1-32(2,36)30(47)41-14-18-6-9-23(34)28(27(18)35)43-31-42-24-11-22(25(12-26(24)44(31)3)45-15-19-10-20(19)16-45)29(46)40-13-17-4-7-21(8-5-17)33(37,38)39/h6,9,11-12,17,19-21H,4-5,7-8,10,13-16H2,1-3H3,(H,40,46)(H,41,47)(H,42,43) |
| InChIKey | HLPCPEPXICVQDA-UHFFFAOYSA-N |
| XLogP | 7.54 |
| TPSA | 91.29 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 47 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 697.61 |
| LogP ≤ 5 | 7.54 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 147801421 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.